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of LV hypertrophy(LV masslbody surface area, 27 vs 13%, p < 0.05). The two
groups had similar serum lipid levels and smoking history. Logistic regres-
sion analysis indicated that age, mean arterial pressure and the presence of
atherosclerosis - but not gender or LV mass - were independently asso-
ciated with higher pulse pressure. The present findings suggest that higher
mean BP mediates the relation of high pulse pressure to changes in cardiac
structure and arterial stiffness in hypertensive patients. However, the inde-
pendent relation of carotid atherosclerosis with higher arterial pulse pressure
confirms the prognostic relevance of higher levels of pulse pressure. 1983-311 A New Coronary Artery Autoperfusion DilatationCatheter
There were no arrhythmias during GAP angioplasty. Similar morphologic
changes in the dilated plaque occurred following GAP and SBA.
Conclusions: Hemodynamic stability and maintenance of distal coronary
flow velocity between 69% and 83% of baseline occur during a 60 minute
inflation with a new autoperfusion angioplasty catheter. The absence of ar-
rhythmias and stable hemodynamics suggest that significant ischemia dur-
ing angioplasty is prevented with this new device. Histopathologic analysis
following GAP angioplasty shows no differences compared to SBA. The GAP
design can be adapted to any standard balloon catheter.
Paul A. Gurbel. R. David Anderson. University of Maryland, Ba/~i71ore, MD
Standard coronary balloon angioplasty (SBA) is limited by the development
of myocardial ischemia during balloon inflation. We describe a new autoper-
fusion dilatation catheter (GAP catheter) where blood flow occurs around the
angioplasty balloon. Arterial morphology changes following GAP angioplasty
were assessed in a swine atherosclerotic plaque model and compared to
SBA (N = 5). In order to assess coronary flow and the development of signif-
icant ischemia during GAP angioplasty, arterial pressure (BP). heart rate (HR),
ECG and distal average peak coronary artery flow velocity(APV) (Doppler flow
wire, Cardiometrics, Inc.) were determined in 7 dogs during 15 seconds of
SBA and 60 minutes of continuous GAP angioplasty in 12 vessel segments,
using 3.0-3.5 mm balloons, inflated to 6 atmospheres pressure. Distal flow
dropped to zero during SBA in all animals. Results during GAP angioplasty
are as follows:
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To evaluate the relationships among dyslipidemia, reduced insulin sensitiv-
ity or insulin resistance, and blood pressure in young and elderly, non-obese,
Japanese male who are living in Osaka, Japan, we undertook this study. In
862 male, consisting 454 young (22-65 yrs, 45 ± 5 (SD) yrs) and 408 el-
derly 166-93 yrs, 78 ± 3 yrs) subjects, blood pressure, fasting blood glucose
(BG), fasting plasma insulin (INS) and norepinephrine (NE). total cholesterol
(T-ch). triglyceride (TG). HDL-ch, VLDL-ch, LDL-ch were measured after more
than 12 hrs fasting in supine position. None had extreme obesity, diabetes
nor family history of diabetes. Young and elderly subjects were matched in
body mass index (22.8 ± 1.0 vs 22.7 ± 0.8 kg/m2 ) and BP status (number of
NT:BHT:EHT. 226:120: 108 vs 200: 119:89). BG and INS were also measured
every 30 min for 2 hrs after 75 g glucose ingestion to calculate area under
the curve {AUC) for BG and INS. Fasting BG, T-ch, VLDL-ch, TG and AUC for
INS were significantly greater in elderly subjects than those in young sub-
jects, but AUC for BG was similar to each other. In young subjects, only T-ch
and fasting INS correlated significantly with mean BP (R = 0.39, P = 0.021,
R = 0.56, P = 0.012), on the other hand, in elderly subjects, TG and VLDL-
ch correlated significantly with mean BP (R = 0.38, P = 0.029, R = 0.49.
P = 0.025), but T-ch did not. In all subjects, regardless BP status and age,
TG, VLDL-ch and fasting INS correlated with mean BP, systolic BP and dias-
tolic BP, and TG and fasting INS correlated with BMI. These results suggest
INS resistance and dyslipidemia appears to be responsible for BP levels in
non-obese Japanese male.
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Reversal of Left Ventricular Hypertrophy in Essential
Hypertension: Meta-Analysis of Studies with High
Scientific Quality
Roland E. Schmieder, Peter Martus, Arnfried Klingbeil. Medizinische Klinik IV,
Universitat Erlangen-NtJberg, Germany
Left ventricular hypertrophy (LVH) is a strong, blood pressure independent
cardiovascular risk factor. Therefore, reversal of LVH appears to be a desir-
able goal in treating arterial hypertension. To determine the ability of various
antihypertensive agents to reduce left ventricular (LV) mass, we analyzed
all published papers with high scientific quality including only dOUble-blind,
randomized, controlled clinical studies with parallel group design. After in-
tensive literature search through the end of 1993, data extraction were per-
formed according to a prefixed scheme independently by two investigators.
Of 432 identified references, only 35 clinical trials fulfilled the criteria of high
scientific quality. We found that the decrease in LVH was greater the higher
was pretreatment LV mass (r = 0.49, P < 0.01), the greater was the fall in
blood pressure (systolic r = 0.43, p < 0.001, diastolic r = 0.26, P < 0.05)
and the longer was the duration of therapy (r = 0.36, P < 0.01). After ad-
justment for different durations of treatment, LV mass fell 16% with ACE-
inhibitors [95% CI: 13.7-20.6%J, 10% with calcium entry blockers [95% CI:
6.0-14.0%],6% with beta-blockers [95% CI: 2.4-9.6%), and 8% with diuret-
ics [95% CI: 3.6-12.6%). There was a significant difference between drug
classes (p < 0.005), and ACE-inhibitors reduced LV mass more than diuret-
ics (p < 0.05) and beta-blockers (p < 0.05). Similar significant differences
between drug classes were found with regard to septal (p < 0.02) and pos-
terior wall thickness (p < 0.03).
The database published through the end of 1993 is small and incom-
plete, and the majority of published studies are of poor scientific quality. Pre-
treatment LV mass, fall in blood pressure, duration of drug treatment, and
drug class determined the reductions observed in LV mass. ACE-inhibitors
and, to a lesser extent, calcium entry blockers emerged as first-line candi-
dates to reduce the risk associated with LVH.
In Vivo Validation of the Hand Pump for Active
Distal Coronary Perfusion During Balloon
Angioplasty in Comparison to Autoperfusion
Catheters
Michael Haude, Dietrich Baumgart, Guido Caspari, Thomas Ehring 1,
Raimund Erbel. Cardiology Department, University of Essen, Essen, Germany;
1 Department of Pathophysiology, University of Essen, Essen, Germany
Standard autoperfusion catheters allow passive distal coronary perfusion
during balloon angioplasty (PTCA) at a reported maximum range of 40 to 60
mllmin. The hand pump uses an active perfusion technique by withdrawing
blood from the guiding catheter and reinjection through the wire lumen of
a standard over-the-wire balloon catheter into the distal vessel. Perfusion is
performed by pulling and pushing the system's piston and is depending on
the applied driving pressure. To test this active perfusion device. heart rate
(HR). mean aortic pressure lAP), dp/dt. regional coronary blood flow (electro-
magnetic flow, EMF) distal to the balloon, systolic regional wall thickening
related to the occluded vessel (sonomicrometry, WT). and distal coronary
perfusion pressure (CPP) were measured in 6 open chest dogs. Measure-
ments were performed at baseline, during two minutes balloon occlusions
(3.0 mm balloon catheter, 6atm) of the left circumflex artery without and with
application of the hand pump at different driving pressures (100 psi, 200 psi,
300 psi and 400 psi), and during two minutes application of a standard 3.0
mm autoperfusion catheter (APC) at 6atm. Before each measurement base-
line hemodynamics were established.
